Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis

Immune checkpoint inhibitors, including cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death-1 (PD-1) inhibitors, represent an effective treatment modality for multiple malignancies. Despite the exciting clinical benefits, checkpoint inhibition is associated with a series of immune-re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Manag Res
Autors principals: Chuzi, Sarah, Tavora, Fabio, Cruz, Marcelo, Costa, Ricardo, Chae, Young Kwang, Carneiro, Benedito A, Giles, Francis J
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5476791/
https://ncbi.nlm.nih.gov/pubmed/28652812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S136818
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars